SELENON and myopathy: As our data suggest that systemic antagonism of TGF-beta re-established skeletal muscle function in SEPN1 mutant mice (Fig. 4), further studies should try to clarify whether interfering with the TGF-beta pathway can be curative in patients affected by SEPN1-related myopathies.